BioLife Solutions, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
BioLife Solutions, Inc. (BLFS) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $11.02 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-09
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.13M, a 39.32% increase year-over-year.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.96M, a 38.79% increase year-over-year.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.56M, a 28.53% increase year-over-year.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $2.37M, a 27.76% increase year-over-year.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $11.02M, a 33.97% increase from fiscal 2016.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $8.23M, a 27.57% increase from fiscal 2015.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $6.45M, a 4.17% increase from fiscal 2014.
- BioLife Solutions, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $6.19M, a 25.77% decline from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.10M derived: sum of 2 quarters · filed 2018-03-09 | $8.66M derived: sum of 3 quarters · filed 2018-03-09 | $11.02M 10-K · filed 2018-03-09 |
| 2017-09-30 | $2.96M 10-Q · filed 2017-11-09 | $5.52M derived: sum of 2 quarters · filed 2017-11-09 | $7.89M 10-Q · filed 2017-11-09 | $10.14M derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $2.56M 10-Q · filed 2017-08-11 | $4.92M 10-Q · filed 2017-08-11 | $7.17M derived: sum of 3 quarters · filed 2018-03-09 | $9.31M derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $2.37M 10-Q · filed 2017-05-12 | $4.62M derived: sum of 2 quarters · filed 2018-03-09 | $6.75M derived: sum of 3 quarters · filed 2018-03-09 | $8.74M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $4.38M derived: sum of 2 quarters · filed 2018-03-09 | $6.37M derived: sum of 3 quarters · filed 2018-03-09 | $8.23M 10-K · filed 2018-03-09 |
| 2016-09-30 | $2.14M 10-Q · filed 2017-11-09 | $4.13M derived: sum of 2 quarters · filed 2017-11-09 | $5.98M 10-Q · filed 2017-11-09 | $7.80M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $1.99M 10-Q · filed 2017-08-11 | $3.84M 10-Q · filed 2017-08-11 | $5.66M derived: sum of 3 quarters · filed 2017-08-11 | $7.29M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $1.85M 10-Q · filed 2017-05-12 | $3.67M derived: sum of 2 quarters · filed 2017-05-12 | $5.30M derived: sum of 3 quarters · filed 2017-05-12 | $6.80M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $3.45M derived: sum of 2 quarters · filed 2017-03-15 | $4.95M derived: sum of 3 quarters · filed 2017-03-15 | $6.45M 10-K · filed 2017-03-15 |
| 2015-09-30 | $1.63M 10-Q · filed 2016-11-10 | $3.13M derived: sum of 2 quarters · filed 2016-11-10 | $4.63M 10-Q · filed 2016-11-10 | $6.30M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $1.50M 10-Q · filed 2016-08-11 | $3.00M 10-Q · filed 2016-08-11 | $4.67M derived: sum of 3 quarters · filed 2016-08-11 | $5.91M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $1.50M 10-Q · filed 2016-05-16 | $3.17M derived: sum of 2 quarters · filed 2016-05-16 | $4.41M derived: sum of 3 quarters · filed 2016-05-16 | $5.63M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $2.91M derived: sum of 2 quarters · filed 2016-02-25 | $4.13M derived: sum of 3 quarters · filed 2016-02-25 | $6.19M 10-K · filed 2016-02-25 |
| 2014-09-30 | $1.24M 10-Q · filed 2015-11-16 | $2.46M derived: sum of 2 quarters · filed 2015-11-16 | $4.52M 10-Q · filed 2015-11-16 | $6.81M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $1.21M 10-Q · filed 2015-08-06 | $3.28M 10-Q · filed 2015-08-06 | $5.57M derived: sum of 3 quarters · filed 2015-08-06 | $7.74M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $2.07M 10-Q · filed 2015-05-07 | $4.35M derived: sum of 2 quarters · filed 2015-05-07 | $6.52M derived: sum of 3 quarters · filed 2015-05-07 | $8.85M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.46M derived: sum of 2 quarters · filed 2015-03-12 | $6.79M derived: sum of 3 quarters · filed 2015-03-12 | $8.34M 10-K · filed 2015-03-12 |
| 2013-09-30 | $2.17M 10-Q · filed 2014-11-06 | $4.50M derived: sum of 2 quarters · filed 2014-11-06 | $6.05M 10-Q · filed 2014-11-06 | $8.09M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | $2.33M 10-Q · filed 2014-08-07 | $3.88M 10-Q · filed 2014-08-07 | $5.92M derived: sum of 3 quarters · filed 2014-08-07 | $7.60M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $1.55M 10-Q · filed 2014-05-08 | $3.59M derived: sum of 2 quarters · filed 2014-05-08 | $5.27M derived: sum of 3 quarters · filed 2014-05-08 | $6.36M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | $3.72M derived: sum of 2 quarters · filed 2014-02-12 | $4.81M derived: sum of 3 quarters · filed 2014-02-12 | $5.64M 10-K · filed 2014-02-12 |
| 2012-09-30 | $1.68M 10-Q · filed 2013-11-14 | $2.77M derived: sum of 2 quarters · filed 2013-11-14 | $3.60M 10-Q · filed 2013-11-14 | $4.40M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $1.09M 10-Q · filed 2013-08-12 | $1.92M 10-Q · filed 2013-08-12 | $2.73M derived: sum of 3 quarters · filed 2013-08-12 | $3.44M derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $830.88K 10-Q · filed 2013-05-14 | $1.64M derived: sum of 2 quarters · filed 2013-05-14 | $2.35M derived: sum of 3 quarters · filed 2013-05-14 | $2.96M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $804.56K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $1.52M derived: sum of 2 quarters · filed 2013-03-29 | $2.13M derived: sum of 3 quarters · filed 2013-03-29 | $2.74M 10-K · filed 2013-03-29 |
| 2011-09-30 | $710.52K 10-Q · filed 2012-11-13 | $1.33M derived: sum of 2 quarters · filed 2012-11-13 | $1.93M 10-Q · filed 2012-11-13 | $2.51M derived: sum of 4 quarters · filed 2012-11-13 |
| 2011-06-30 | $617.85K 10-Q · filed 2012-08-14 | $1.22M 10-Q · filed 2012-08-14 | $1.79M derived: sum of 3 quarters · filed 2012-08-14 | $2.31M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $605.80K 10-Q · filed 2012-05-14 | $1.18M derived: sum of 2 quarters · filed 2012-05-14 | $1.70M derived: sum of 3 quarters · filed 2012-05-14 | $2.16M derived: sum of 4 quarters · filed 2012-05-14 |
| 2010-12-31 | $570.99K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $1.09M derived: sum of 2 quarters · filed 2012-03-29 | $1.55M derived: sum of 3 quarters · filed 2012-03-29 | $2.06M 10-K · filed 2012-03-29 |
| 2010-09-30 | $519.89K 10-Q · filed 2011-11-14 | $982.66K derived: sum of 2 quarters · filed 2011-11-14 | $1.49M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $462.77K 10-Q · filed 2011-08-12 | $970.68K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |